StockTipsArenaBeta

BUY Gland Pharma Limited — Prakash Gaba

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))29 Jul 2026via CNBC Awaaz.

Entry₹2,535.5Inferred
Target₹2,600
Total upside +2.54% (call closed)
Stop loss₹2,500-1.40% risk
Exit₹2,50030 Jul 2026, 10:40 am
Stop-loss hit-1.40%
Follow Prakash Gaba for new calls(30% target hit, 295 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 152 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Jul 2026
3 supporting1 opposing
Supports the BUY call (3)

Gland Pharma Ltd has received approval for its Suggamadex Injection.

BSE · Company Update·29 Jul · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·30 Jul · today

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·24 Jul · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Prakash Gaba

Every call and its outcome